NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment

Multiple myeloma (MM) has witnessed improved patient outcomes through advancements in therapeutic approaches. Notably, allogeneic stem cell transplantation, proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies have contributed to enhanced quality of life. Recently, a promising av...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Benjamin Motais, Sandra Charvátová, Zuzana Walek, Roman Hájek, Juli R. Bagó
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Subjects:	cancer multiple myeloma natural killer immunotherapy chimeric antigen receptor allogenic
Online Access:	https://www.mdpi.com/2073-4409/12/23/2748